Indivior et al v. Actavis Laboratories UT > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jul 9, 2020 | 19 | Motion to Continue (3) |
Jul 9, 2020 | 16 | Motion for Extension of Time to File Answer (3) |
Jul 9, 2020 | 13 | Motion for Extension of Time to File Answer (3) |
Jul 9, 2020 | 7 | Motion for Extension of Time to File Answer (3) |
May 3, 2018 | N/A | Terminated Case (0) Docket Text: Civil Case Terminated per [20] Notice of Voluntary Dismissal. (las) |
May 3, 2018 | 21 | Report Regarding Patent and Trademark (1) Docket Text: Report on the Final Decision of an action sent to the Director of the U.S. Patent and Trademark Office. (las) |
May 2, 2018 | 20 | Main Document (2) Docket Text: NOTICE of Voluntary Dismissal filed by Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited (Attachments: # (1) Text of Proposed Order proposed Order) (Berger, Arthur) |
May 2, 2018 | 20 | Notice of Voluntary Dismissal (2) |
May 2, 2018 | 20 | Text of Proposed Order proposed Order (2) |
Apr 19, 2018 | 19 | Main Document (3) Docket Text: Stipulated MOTION to Continue the Initial Pretrial Conference filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulation and Joint Motion to Reschedule the Initial Pretrial Conference)(Gehret, Michael) |
Apr 19, 2018 | 19 | Text of Proposed Order Proposed Order Granting Stipulation and Joint Motion to R (2) |
Apr 18, 2018 | 18 | Order on Motion for Extension of Time to Answer (1) Docket Text:ORDER granting [16] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 5/3/2018. Signed by Magistrate Judge Dustin B. Pead on 4/18/2018. (las) |
Apr 17, 2018 | 16 | Main Document (3) Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Order Granting Stipulated MOtion for Extension of Time)(Gehret, Michael) |
Apr 17, 2018 | 16 | Text of Proposed Order Order Granting Stipulated MOtion for Extension of Time (2) |
Apr 17, 2018 | N/A | Received Consent to US Magistrate Judge Form (0) Docket Text: RECEIVED Consent/Reassignment Form from Defendant Actavis Laboratories UT. (las) |
Apr 16, 2018 | 15 | Notice of Presiding Magistrate Assignment Reminder (1) Docket Text: NOTICE REMINDER - All parties are requested to respond within the time frame set forth in the [10] Notice of Presiding Magistrate Assignment,, pursuant to General Order 07-001. If you have already consented/objected, please disregard this notice. No judge will be informed of a party's response unless all parties have consented to the assignment of the matter to a U.S. Magistrate Judge. Unless consents from all parties are received within fifteen(15) days, the case will be randomly re-assigned to a U.S. District Judge without further notice. Link to Magistrate Consent Objection form (las) |
Apr 4, 2018 | 14 | Order on Motion for Extension of Time to Answer (1) Docket Text:ORDER granting [13] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 4/19/2018. Signed by Magistrate Judge Dustin B. Pead on 4/4/2018. (las) |
Apr 3, 2018 | 13 | Text of Proposed Order Proposed Order Granting Stipulated Motion for Extention o (2) |
Apr 3, 2018 | 13 | Main Document (3) Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulated Motion for Extention of Time)(Gehret, Michael) |
Apr 2, 2018 | N/A | Notice of Hearing (0) Docket Text:NOTICE OF INITIAL PRETRIAL CONFERENCE:: (Notice generated by IPT Clerk) The Attorneys Planning Meeting Report and Proposed Scheduling Order forms, available on the court web site at http://www.utd.uscourts.gov/usdc-forms, should be prepared 21 days before the Initial Pretrial Conference hearing date. NOTICE TO COUNSEL, The Court may enter a scheduling order and vacate the hearing if counsel (a) file a stipulated Attorneys Planning Meeting Report; and (b) e-mail a Proposed Scheduling Order to ipt@utd.uscourts.gov 21 days before the scheduled hearing. See instructions at http://www.utd.uscourts.gov/attorney-planning-meeting-and-report If counsel or the parties would like to participate by phone they must contact the IPT Clerk at least two days in advance at ipt@utd.uscourts.gov to make arrangements. Initial Pretrial Conference set for 5/9/2018 at 11:00 AM in Rm 7.400 before Magistrate Judge Evelyn J. Furse. (jds) |
Mar 29, 2018 | 8 | Notice of ADR (1) Docket Text: NOTICE OF ADR, e-mailed or mailed to Defendant Actavis Laboratories UT, Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited. (las) |
Mar 29, 2018 | N/A | Notice From the Court re Initial Scheduling (0) Docket Text: NOTICE FROM THE COURT re: Initial Scheduling The court's IPT Clerk will now set the case for the Initial Pretrial Scheduling Conference (las) |
Mar 29, 2018 | 10 | Notice of Presiding Magistrate Assignment (1) Docket Text: NOTICE - This case is assigned to a magistrate judge. To consent or request reassignment, use the form on this link or use the included form for non-efilers and send it to consents@utd.uscourts.gov within 15 days or mail to the court with Attention: Consent Clerk on the envelope. Notice e-mailed or mailed to Defendant Actavis Laboratories UT, Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited. Form due by 4/13/2018. (las) |
Mar 29, 2018 | 11 | Order on Motion for Extension of Time to Answer (1) Docket Text:ORDER granting [7] Motion for Extension of Time to Answer re [2] Complaint. Answer deadline updated for Actavis Laboratories UT answer due 4/5/2018. Signed by Magistrate Judge Dustin B. Pead on 3/29/2018. (las) |
Mar 28, 2018 | 7 | Text of Proposed Order Proposed Order Granting Stipulated Motion for Extension o (2) |
Mar 28, 2018 | 7 | Main Document (3) Docket Text: Stipulated MOTION for Extension of Time to File Answer re [2] Complaint, filed by Defendant Actavis Laboratories UT. (Attachments: # (1) Text of Proposed Order Proposed Order Granting Stipulated Motion for Extension of Time) Attorney Michael A. Gehret added to party Actavis Laboratories UT(pty:dft)(Gehret, Michael) |
Feb 8, 2018 | 4 | Rule 7 Corporate Disclosure Statement (3) Docket Text: CORPORATE DISCLOSURE STATEMENT under FRCP 7.1 filed by Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited identifying Indivior Finance LLC as Corporate Parent. (Berger, Arthur) |
Feb 7, 2018 | 2 | Complaint (7) |
Feb 7, 2018 | 2 | Main Document (7) Docket Text: COMPLAINT against Actavis Laboratories UT (Filing fee $ 400, receipt number 1088-2935499) filed by Indivior UK Limited, Indivior, Aquestive Therapeutics. (Attachments: # (1) Exhibit A-US 9,855,221, # (2) Civil Cover Sheet Cover Sheet) Assigned to Magistrate Judge Dustin B. Pead (Berger, Arthur) |
Feb 7, 2018 | 1 | Remark - New Case (1) Docket Text: Case has been indexed and assigned to Magistrate Judge Dustin B. Pead. Plaintiffs Aquestive Therapeutics, Indivior, Indivior UK Limited is directed to E-File the Complaint and cover sheet (found under Complaints and Other Initiating Documents) and pay the filing fee of $ 400.00 by the end of the business day. NOTE: The court will not have jurisdiction until the opening document is electronically filed and the filing fee paid in the CM/ECF system. Civil Summons may be issued electronically. Prepare the summons using the courts PDF version and email it to utdecf_clerk@utd.uscourts.gov for issuance. (nl) |
Feb 7, 2018 | 3 | Report Regarding Patent and Trademark (1) Docket Text: Report on the Filing of an action sent to the Director of the U.S. Patent and Trademark Office. (nl) |
Feb 7, 2018 | 2 | Civil Cover Sheet Cover Sheet (1) |
Feb 7, 2018 | 2 | Exhibit A-US 9,855,221 (36) |
Feb 7, 2018 | 2 | Complaint* (1) |